These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 35415751)

  • 21. Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy.
    Chan GC; Eng DG; Miner JH; Alpers CE; Hudkins K; Chang A; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1680-F1694. PubMed ID: 31630546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connexin 43‑autophagy loop in the podocyte injury of diabetic nephropathy.
    Ji J; Zhao Y; Na C; Yang M; Zhu X; Shi H; Gan W; Zhang A
    Int J Mol Med; 2019 Nov; 44(5):1781-1788. PubMed ID: 31545399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
    J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.
    Toffoli B; Zennaro C; Winkler C; Giordano Attianese GMP; Bernardi S; Carraro M; Gilardi F; Desvergne B
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1154-F1165. PubMed ID: 29488390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.
    Lin J; Shi Y; Peng H; Shen X; Thomas S; Wang Y; Truong LD; Dryer SE; Hu Z; Xu J
    J Pathol; 2015 May; 236(1):30-40. PubMed ID: 25641678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
    Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.
    Cheng H; Fan X; Moeckel GW; Harris RC
    J Am Soc Nephrol; 2011 Jul; 22(7):1240-51. PubMed ID: 21737546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy.
    Kumar PA; Kotlyarevska K; Dejkhmaron P; Reddy GR; Lu C; Bhojani MS; Menon RK
    J Biol Chem; 2010 Oct; 285(41):31148-56. PubMed ID: 20682777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.
    Ren G; Tardi NJ; Matsuda F; Koh KH; Ruiz P; Wei C; Altintas MM; Ploegh H; Reiser J
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F471-F482. PubMed ID: 29167172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirtuins as novel pharmacological targets in podocyte injury and related glomerular diseases.
    Liu T; Yang L; Mao H; Ma F; Wang Y; Li S; Li P; Zhan Y
    Biomed Pharmacother; 2022 Nov; 155():113620. PubMed ID: 36122519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
    Ma R; Xu Y; Zhou H; Zhang D; Yao D; Song L; Liu Y
    Mol Med Rep; 2019 Mar; 19(3):2421-2430. PubMed ID: 30664212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of High Glucose and Lipotoxicity on Diabetic Podocytes.
    Nakamichi R; Hayashi K; Itoh H
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33467659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease.
    Sun Y; Cui S; Hou Y; Yi F
    Kidney Dis (Basel); 2021 Nov; 7(6):438-451. PubMed ID: 34901191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Podocyte Bioenergetics in the Development of Diabetic Nephropathy: The Role of Mitochondria.
    Audzeyenka I; Bierżyńska A; Lay AC
    Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34791124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis.
    Guo J; Ananthakrishnan R; Qu W; Lu Y; Reiniger N; Zeng S; Ma W; Rosario R; Yan SF; Ramasamy R; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2008 May; 19(5):961-72. PubMed ID: 18256352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.